Skip to main content

Hotel and vacation operator Marriott International (MAR) on Friday revealed that CEO Arne Sorenson will undergo chemotherapy treatment for stage 2 pancreatic cancer.

In a statement, Sorenson, 60, noted the cancer was discovered early, has not spread and is highly treatable - and that he and his medical team "are confident that we can realistically aim for a complete cure."

"In the meantime, I intend to continue working at the company I love. We have great work underway at Marriott. I am as excited by what we can accomplish together as I have ever been."

Scroll to Continue

TheStreet Recommends

Sorenson will remain in his role as active CEO while undergoing treatment. Surgery is anticipated near the end of the year.

Shares of Marriott were up 1.15% at $138.54 in early trading on the Nasdaq Stock Exchange on Friday. They ended the trading day Thursday down 1.4%, or $1.97, at $136.89.